Characterization and functional assessment of mouse PPARγ1 promoter

Avicenna Journal of Medical Biotechnology

Volumn 4, Issue 4, 2012, Pages 160-169

  Lachinani, Liana ^a   Ghaedi, Kamran ^a,b   Tanhaei, Somayeh ^a   Salamian, Ahmad ^a   Karamali, Fereshteh ^a   Kiani Esfahani, Abbas ^a   Rabiee, Farzaneh ^a   Yaghmaei, Parichehreh ^d   Baharvand, Hossein ^a,c   Nasr Esfahani, Mohammad Hossein ^a  

^a ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

^b UNIVERSITY OF ISFAHAN   (Iran)

^c UNIVERSITY OF SCIENCE AND CULTURE   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Gene expression; Mouse; PPAR gamma

Indexed keywords

COMPLEMENTARY DNA; HETERODIMER; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOID X RECEPTOR; ROSIGLITAZONE; VITAMIN D; VITAMIN D RECEPTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CELL MIGRATION; EMBRYOID BODY; GENE AMPLIFICATION; GENE EXPRESSION; MOLECULAR CLONING; MOUSE; NERVE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; RECEPTOR BINDING; REPORTER GENE; STEM CELL;

EID: 84867147992     PISSN: 20082835     EISSN: 20084625     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Michalik L, Auwerx J, Berger JP, Chatterjee VK, Glass CK, Gonzalez FJ, et al. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol Rev 2006;58(4): 726-741.
2. Clarke SD, Thuillier P, Baillie RA, Sha X. Peroxi-some proliferator-activated receptors: a family of lipid-activated transcription factors. Am J Clin Nutr 1999;70(4):566-571.
3. Berger J, Moller DE. The mechanisms of action of PPARs. Annu Rev Med 2002;53:409-435.
4. Fajas L, Debril MB, Auwerx J. Peroxisome prolif-erator-activated receptor-gamma: from adipogen-esis to carcinogenesis. J Mol Endocrinol 2001;27 (1):1-9.
5. Ghoochani A, Shabani K, Peymani M, Ghaedi K, Karamali F, Karbalaei K, et al. The influence of pe-roxisome proliferator-activated receptor γ1 during differentiation of mouse embryonic stem cells to neural cells. Differentiation 2012;83(1):60-67.
6. Zhu Y, Qi C, Korenberg JR, Chen X, Noya D, Rao MS, et al. Structural organization of mouse peroxi-some proliferator activated receptor γ (mPPARγ) gene: Alternative promoter use and different splicing yield two mPPARγ isoforms. Proc Natl Acad Sci USA 1995;92(17):7921-7925.
7. Fajas L, Auboeuf D, Raspe E, Schoonjans K, Lefe-bvre A, Saladin R, et al. The organization, promoter analysis, and expression of the human PPARγ gene. J Biol Chem 1997;272(30):18779-18789.
8. Baharvand H, Matthaei KI. Culture condition difference for establishment of new embryonic stem cell lines from the C57BL/6 and BALB/c mouse strains. In Vitro Cell Dev Biol Anim 2004;40(3-4):76-81.
9. Ostadsharif M, Ghaedi K, Nasr-Esfahani MH, Moj-bafan M, Tanhaie S, Karbalaie K, et al. The expression of peroxisomal protein transcripts increased by retinoic acid during neuronal differentiation. Differentiation 2011;81(2):127-132.
10. Kapadia R, Yi JH, Vemuganti R. Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists. Front Biosci 2008;13: 1813-1826.
11. Feige JN, Gelman L, Michalik L, Desvergne B, outputs: Peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. Prog Lipid Res 2006;45(2):120-159.
12. Sertznig P, Seifert M, Tilgen W, Reichrath J. Activation of vitamin D receptor (VDR)- and peroxi-some proliferator-activated receptor (PPAR)-sig-naling pathways through 1,25(OH)2D3 in melano ma cell lines and other skin-derived cell lines. Der-matoendocrinol 2009;1(4):232-238.
13. Levenson CW, Figueiroa SM. Gestational vitamin D deficiency: long-term effects on the brain. Nutr Rev 2008;66(12):726-729.
14. Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 2002;13(3):100-105.
15. Wood RJ. Vitamin D and adipogenesis: new molecular insights. Nutr Rev 2008;66(1):40-46.